Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4J9HV
|
|||
| Drug Name |
ABBV-011
|
|||
| Drug Type |
Antibody drug conjugate
|
|||
| Indication | Small-cell lung cancer [ICD-11: 2C25.Y] | Phase 1 | [1] | |
| Company |
AbbVie
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03639194) A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.